These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1469690)
21. Specific Inhibition of Bacterial β-Glucuronidase by Pyrazolo[4,3-c]quinoline Derivatives via a pH-Dependent Manner To Suppress Chemotherapy-Induced Intestinal Toxicity. Cheng KW; Tseng CH; Yang CN; Tzeng CC; Cheng TC; Leu YL; Chuang YC; Wang JY; Lu YC; Chen YL; Cheng TL J Med Chem; 2017 Nov; 60(22):9222-9238. PubMed ID: 29120626 [TBL] [Abstract][Full Text] [Related]
22. Pyrazolo[3,4-h]quinolines promising photosensitizing agents in the treatment of cancer. Spanò V; Parrino B; Carbone A; Montalbano A; Salvador A; Brun P; Vedaldi D; Diana P; Cirrincione G; Barraja P Eur J Med Chem; 2015 Sep; 102():334-51. PubMed ID: 26295175 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail. Hayat F; Salahuddin A; Umar S; Azam A Eur J Med Chem; 2010 Oct; 45(10):4669-75. PubMed ID: 20696501 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives. Sun XY; Wu R; Wen X; Guo L; Zhou CP; Li J; Quan ZS; Bao J Eur J Med Chem; 2013 Feb; 60():451-5. PubMed ID: 23321259 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Engers DW; Frist AY; Lindsley CW; Hong CC; Hopkins CR Bioorg Med Chem Lett; 2013 Jun; 23(11):3248-52. PubMed ID: 23639540 [TBL] [Abstract][Full Text] [Related]
33. A convenient synthesis of new substituted pyrazolo[4,3-c]quinolines with potential antiinflammatory activity. Mekheimer R Pharmazie; 1994 Jul; 49(7):486-9. PubMed ID: 8073058 [TBL] [Abstract][Full Text] [Related]
34. [Studies on the syntheses of chemotherapeutics. V. Synthesis of the pyrazolo-[4,3-f]- and [3,4-f]quinoline-8-carboxylic acid derivatives (studies on the syntheses of heterocyclic compounds. DCCLVI) (author's transl)]. Kametani T; Kigasawa K; Hiiragi M; Wakisaka K; Haga S; Kusama O; Sugi H; Tanigawa K Yakugaku Zasshi; 1978 Aug; 98(8):1063-71. PubMed ID: 712569 [No Abstract] [Full Text] [Related]
35. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants. Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and SAR study of novel tricyclic pyrazoles as potent phosphodiesterase 10A inhibitors. Dore A; Asproni B; Scampuddu A; Pinna GA; Christoffersen CT; Langgård M; Kehler J Eur J Med Chem; 2014 Sep; 84():181-93. PubMed ID: 25016376 [TBL] [Abstract][Full Text] [Related]
37. Semi-synthetic aristolactams--inhibitors of CDK2 enzyme. Hegde VR; Borges S; Pu H; Patel M; Gullo VP; Wu B; Kirschmeier P; Williams MJ; Madison V; Fischmann T; Chan TM Bioorg Med Chem Lett; 2010 Feb; 20(4):1384-7. PubMed ID: 20097066 [TBL] [Abstract][Full Text] [Related]
38. Imidazo[4,5-c]quinolines as inhibitors of the PI3K/PKB-pathway. Stauffer F; Maira SM; Furet P; García-Echeverría C Bioorg Med Chem Lett; 2008 Feb; 18(3):1027-30. PubMed ID: 18248814 [TBL] [Abstract][Full Text] [Related]
39. Pyrazolo[4,5-c]quinolines. 2. Synthesis and specific inhibition of benzodiazepine receptor binding. Melani F; Cecchi L; Palazzino G; Filacchioni G; Martini C; Pennacchi E; Lucacchini A J Med Chem; 1986 Feb; 29(2):291-5. PubMed ID: 3005571 [TBL] [Abstract][Full Text] [Related]